Year: 2025
Type: article
Abstract: Comment on: Sinha S, Nigwekar SU, Brandenburg V, Gould LJ, Serena TE, Moe SM, Aronoff GR, Chatoth DK, Hymes JL, Carroll KJ, Alperovich G, Keller LH, Perelló J, Gold A, Chertow GM. Hexasodium fytate for the treatment of calciphylaxis: a randomised, double-blind, phase 3, placebo-controlled trial with an open-label extension. EClinicalMedicine. 2024 Aug 16;75:102784. doi: 10.1016/j.eclinm.2024.102784.
Source: Clinical Kidney Journal
DOI: 10.1093/ckj/sfaf193
Authors: Marieta Theodorakopoulou, Björn Meijers
Institutions: Aristotle University of Thessaloniki, KU Leuven
Language: English
Subfield: Nephrology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $3,335
OpenAlex ID: W4411715693